
FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis
AbstractObjectiveTo analyze the US Food and Drug Administration (FDA) approval, trials, unmet needs, benefit, and…






.jpg)















